schistocyte

Schistocytes result from intravascular mechanical trauma to red blood cells. This occurs classically in microangiopathic hemolytic anemias, where fibrin strands or platelet microthrombi deposited in small vessels shear RBCs as they pass through, producing fragmented cells (helmet cells, triangle cells, small irregular fragments). Key causes include thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), disseminated intravascular coagulation (DIC), HELLP syndrome, malignant hypertension, and mechanical trauma from prosthetic heart valves or severe vasculitis. Pathophysiologically, the underlying process involves endothelial injury, platelet aggregation, and/or fibrin deposition, which narrows the vessel lumen and creates shear forces that fragment RBCs as they attempt to pass through.

Clinically, schistocytes are identified on peripheral blood smear and are a key diagnostic clue when evaluating hemolytic anemia. Their presence, combined with thrombocytopenia and elevated LDH/indirect bilirubin with a negative direct Coombs test, points toward MAHA rather than immune-mediated hemolysis (which would show spherocytes and a positive Coombs test). The clinical context helps narrow the differential: fever, renal failure, and neurologic symptoms suggest TTP/HUS; hypertension and proteinuria in pregnancy suggest HELLP; and abnormal coagulation studies (elevated PT/PTT, low fibrinogen, elevated D-dimer) suggest DIC. Recognizing schistocytes promptly is crucial because conditions like TTP are medical emergencies requiring urgent plasma exchange therapy.